openPR Logo
Press release

Heart Failure Diagnostics/Therapeutics Market : Abbott Laboratories, Beckman Coulter, Abiomed Inc., Berlin Heart GmbH, Biotronik SE & Co. KG, Boston Scientific Corporation, HeartWare International Inc.

10-09-2018 10:25 AM CET | Health & Medicine

Press release from: Allied Market Research

Heart failure or congestive heart failure is a phenomenon, which occurs when the heart muscle is not able to pump blood properly or when it leads to conditions such as high blood pressure, high cholesterol level, narrowing of blood vessels, and others. Heart failure diagnosis can be done by various ways such as blood tests, electrocardiogram chest x-ray, echocardiogram, and others.

The key players profiled include Abbott Laboratories, Beckman Coulter, Abiomed Inc., Berlin Heart GmbH, Biotronik SE & Co. KG, Boston Scientific Corporation, HeartWare International Inc., Jarvik Heart Inc., Medtronic plc, and St. Jude Medical.

Get Sample PDF Brochure : https://www.alliedmarketresearch.com/request-toc-and-sample/4129

Growth in incidence of heart failure, rise in incidence of diabetes, atherosclerosis, stroke, hypertension, and other conditions, technological advancements in cardiac heart failure treatment devices, sedentary lifestyle habits, and growth in geriatric population drive the market growth. However, reimbursement issues and high cost of diagnosing devices in the emerging countries are some of the factors that restrict the market growth. Moreover, new emerging technologies of cardiovascular treatment & diagnostics generate numerous opportunities in untapped markets in the near future.

The market is segmented on the basis of therapy, product, tests, and region. On the basis of therapy, it is divided into cardiac resynchronization therapy, ventricular assist devices, counterpulsation implants, heart failure surgery, fluid reduction, neurostimulation, hemodynamic monitoring, and central sleep apnea. On the basis of product, it is classified into electrocardiogram systems, holter monitors, event monitors, and implantable loop recorders.
On the basis of tests, it is categorized into electrocardiogram, blood tests, troponin, CK-MB, and others. By geography, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, UK, France, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).

Key Benefits

• The study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets.
• It offers a quantitative analysis from 2016 to 2023, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
• Extensive analysis by product helps understand various types of therapies used for heart failure diagnostics.
• Comprehensive analysis of all geographical regions is provided, which helps determine the prevailing opportunities.
• Key players are profiled and their strategies are analyzed thoroughly, which elucidates the competitive outlook of the global market.

Heart Failure Diagnostics/Therapeutics Market Key Segments:

By Therapy

• Cardiac Resynchronization Therapy
• Ventricular Assist Devices
• Counterpulsation Implants
• Heart Failure Surgery
• Fluid Reduction (Renal Impairment)
• Neurostimulation
• Hemodynamic Monitoring
• Central Sleep Apnea

By Product
• ECG Systems
• Holter Monitors
• Event Monitors
• Implantable Loop Recorders

By Tests
• Blood Tests
• Chest X-Ray
• Electrocardiogram (ECG)
• Echocardiogram
• Stress Test
• Cardiac Computerized Tomography (CT) Scan or Magnetic Resonance
Imaging (MRI)
• Coronary Angiogram
• Myocardial Biopsy

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

David C
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Heart Failure Diagnostics/Therapeutics Market : Abbott Laboratories, Beckman Coulter, Abiomed Inc., Berlin Heart GmbH, Biotronik SE & Co. KG, Boston Scientific Corporation, HeartWare International Inc. here

News-ID: 1289883 • Views:

More Releases from Allied Market Research

3D Printing Filament Market Comprehensive Growth Outlook and Trend Analysis, 2024-2031
3D Printing Filament Market Comprehensive Growth Outlook and Trend Analysis, 202 …
According to the report, the global 3D printing filament market was valued at $0.9 billion in 2023 and is projected to reach $2.3 billion by 2031, registering a CAGR of 12.8% from 2024 to 2031. Download Sample Pages of Research Overview: https://www.alliedmarketresearch.com/3d-printing-filament-market-A11572 Key Growth Drivers: The growth of the 3D printing filament market is fueled by continuous advancements in filament materials-such as carbon fiber-reinforced composites, metal-infused filaments, and high-performance engineering plastics. These innovations
Wet Chemicals Market Detailed Analysis, Growth Trends, and Future Outlook 2025-2031
Wet Chemicals Market Detailed Analysis, Growth Trends, and Future Outlook 2025-2 …
According to a recent report by Allied Market Research (AMR), the global wet chemicals market is poised for substantial growth, projected to reach a value of $5.9 billion by 2031, up from $3.2 billion in 2021. This comprehensive analysis explores market dynamics, growth drivers, and strategic initiatives while highlighting key opportunities across regions and industry segments. Download Sample Pages of Research Overview: https://www.alliedmarketresearch.com/request-sample/A17425 The study delves into development trends, investment frameworks, and
Nonwoven Fabrics Market Outlook to 2033 Projected High CAGR and Growth Opportunities
Nonwoven Fabrics Market Outlook to 2033 Projected High CAGR and Growth Opportuni …
A new report titled "Nonwoven Fabrics Market by Polymer Type (Polypropylene (PP), Polyethylene (PE), Polyethylene Terephthalate (PET), Wood Pulp, Rayon, and Others), Function (Disposables and Durables), Technology (Spunbond, Dry Laid, Air Laid, Wet Laid, Meltblown, and Others), and Application (Hygiene, Wipes, Medical, Filtration, Automotive, Building & Construction, and Others): Global Opportunity Analysis and Industry Forecast, 2024-2033" has been released by Allied Market Research. Key Highlights: - Market Size (2023): $58.4 Billion - Projected
Utilities Asset Management Market Poised for 11.3% CAGR Growth, Key Players, Market Size, Share, and Emerging Trends through 2031
Utilities Asset Management Market Poised for 11.3% CAGR Growth, Key Players, Mar …
According to the report published by Allied Market Research, the global utilities asset management market generated $4.3 billion in 2021, and is projected to reach $12.4 billion by 2031, growing at a CAGR of 11.3% from 2022 to 2031. The report offers a detailed analysis of the top winning strategies, evolving market trends, market size and estimations, value chain, key investment pockets, drivers & opportunities, competitive landscape and regional landscape.

All 5 Releases


More Releases for Heart

Heart Healthy Foods and Supplements vs Heart Conditions
Heart conditions remain a major health concern worldwide, but the good news is that specific heart healthy foods and supplements can significantly improve cardiovascular health. Scientific research has demonstrated that certain foods, nutrients and supplements support heart function, reduce inflammation, and lower the risk of heart disease. Top Heart Healthy Foods Fatty Fish - Salmon, mackerel, and sardines are rich in omega-3 fatty acids, which help lower blood pressure and reduce inflammation. A
Centrifugal Heart Pumps Market | Abbott Laboratories, Abiomed, Berlin Heart, Car …
The global centrifugal heart pumps market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the centrifugal heart pumps market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants. From the perspective of market dynamics, this report explores the factors driving the growth
Heart disease and Heart Attacks - Kaffailham.gr
Καρδιολόγος Αθηνα - https://kaffailham.gr When people talk about heart disease or heart attacks. The arteries that they are talking about are the arteries that actually provide blood to the heart. Remember the heart itself is a muscle. It itself needs oxygen. So you have these arteries right over here, the red tubes. Those are arteries. and then the blue ones are veins. They're taking the de-oxygenated blood away from the tissue
Artificial Heart Implant Market May See a Big Move | Major Giants Jarvik Heart, …
The Latest survey report on Artificial Heart Implant Market sheds lights on changing dynamics of each of the subsegments of Industry. As the shift to value continues, Artificial Heart Implant organizations have the dual challenge of increasing interoperability to improve clinical performance and the patient experience. Some of the companies listed in the study from complete survey list are Medtronic, Boston Scientific, Abbott, Terumo, B.Braun, SynCardia, BiVACOR, CARMAT, ReinHeart TAH
HEART PUMP DEVICES Market 2020 | SWOT Analysis By Top Players Abbott Laboratorie …
A detailed study on HEART PUMP DEVICES Market formulated by Brandessence Market Research, puts together a concise analysis of the growth factors impacting the current business scenario across assorted regions. Significant information pertaining to the industry's size, share, application, and statistics are also summed in the report in order to present an ensemble prediction. In addition, this report undertakes an accurate competitive analysis illustrating the status of market majors in
Heart Pump Device Market - Potential Innovations 2025 | Terumo, Jarvik Heart
Heart Pump Device Market: Snapshot Heart pump devices are essentially mechanical pumps playing the role of ventricular assist devices. These are surgically implanted and are used for temporarily supporting the functions of heart in people with weak heart or irregular blood flow. These devices are notably used as a bridge to cardiac transplantation for patients suffering with end stage heart failure. They can also be used in patients during and after